Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Extranodal NK/T-cell lymphoma, nasal type, with extranasal presentation - a case report and a review of the literature

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Voluntary wheel running can lead to modulation of immune checkpoint molecule expression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Abnormal eosinophil count at CLL diagnosis correlates with shorter treatment free survival

    Publikation: Bidrag til tidsskriftLetterpeer review

  3. Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Evaluation of topical morphine for treatment of oral mucositis in cancer patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

Vis graf over relationer
OriginalsprogEngelsk
TidsskriftActa Oncologica
Vol/bind59
Udgave nummer12
Sider (fra-til)1547-1551
Antal sider5
ISSN0284-186X
DOI
StatusUdgivet - dec. 2020

ID: 61630784